Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-12-06 1:47 pm Purchase | 13G | Benitec Biopharma Inc. BNTC | JANUS HENDERSON GROUP PLC JHG | 2,692,410 11.600% | 1,815,887 (+207.17%) | View |
| 2024-11-18 4:36 pm Purchase | 13D | Benitec Biopharma Inc. BNTC | SUVRETTA CAPITAL MANAGEMENT LLC | 14,329,937 49.900% | 5,500,884 (+62.30%) | View |
| 2024-11-14 1:37 pm Sale | 13G | Benitec Biopharma Inc. BNTC | JANUS HENDERSON GROUP PLC JHG | 876,523 8.300% | -1,805,752 (-67.32%) | View |
| 2024-11-13 4:18 pm Purchase | 13G | Benitec Biopharma Inc. BNTC | HBM Healthcare Investments (Cayman) Ltd. | 1,041,669 9.700% | 191,776 (+22.56%) | View |
| 2024-11-06 3:26 pm Unchanged | 13G | Benitec Biopharma Inc. BNTC | JANUS HENDERSON GROUP PLC JHG | 2,682,275 13.500% | 0 (Unchanged) | View |
| 2024-10-25 2:19 pm Purchase | 13G | Benitec Biopharma Inc. BNTC | JANUS HENDERSON GROUP PLC JHG | 2,682,275 13.500% | 2,501,876 (+1386.86%) | View |
| 2024-09-30 5:18 pm Purchase | 13D | Benitec Biopharma Inc. BNTC | SUVRETTA CAPITAL MANAGEMENT LLC | 8,829,053 49.900% | 7,128,203 (+419.10%) | View |
| 2024-04-29 4:08 pm Purchase | 13D | Benitec Biopharma Inc. BNTC | SUVRETTA CAPITAL MANAGEMENT LLC | 1,700,850 19.990% | 1,438,007 (+547.10%) | View |
| 2024-04-29 4:05 pm Purchase | 13G | Benitec Biopharma Inc. BNTC | HBM Healthcare Investments (Cayman) Ltd. | 849,893 9.990% | 849,893 (New Position) | View |
| 2024-04-29 11:44 am Purchase | 13G | Benitec Biopharma Inc. BNTC | Oliveira Steven Michael | 791,235 8.890% | 693,032 (+705.71%) | View |
| 2024-04-11 12:10 pm Purchase | 13G | Benitec Biopharma Inc. BNTC | ADAGE CAPITAL PARTNERS GP L.L.C. | 264,510 9.990% | 75,322 (+39.81%) | View |
| 2024-02-14 6:18 pm Sale | 13G | Benitec Biopharma Inc. BNTC | CITADEL ADVISORS LLC | 95,356 3.600% | -84,674 (-47.03%) | View |
| 2024-02-14 10:00 am Sale | 13G | Benitec Biopharma Inc. BNTC | JANUS HENDERSON GROUP PLC JHG | 180,399 7.000% | -25,771 (-12.50%) | View |
| 2024-02-13 5:16 pm Purchase | 13G | Benitec Biopharma Inc. BNTC | SUVRETTA CAPITAL MANAGEMENT LLC | 262,843 9.990% | 262,843 (New Position) | View |
| 2023-12-11 12:41 pm Purchase | 13G | Benitec Biopharma Inc. BNTC | FRANKLIN RESOURCES INC BEN | 588,237 22.900% | 2 (+0.00%) | View |
| 2023-09-11 11:27 am Purchase | 13G | Benitec Biopharma Inc. BNTC | FRANKLIN RESOURCES INC BEN | 588,235 28.500% | 588,235 (New Position) | View |
| 2023-08-25 4:30 pm Purchase | 13G | Benitec Biopharma Inc. BNTC | ADAGE CAPITAL PARTNERS GP L.L.C. | 189,188 7.500% | 189,188 (New Position) | View |
| 2023-08-21 4:07 pm Purchase | 13G | Benitec Biopharma Inc. BNTC | CITADEL ADVISORS LLC | 180,030 6.900% | 180,030 (New Position) | View |
| 2023-08-18 3:55 pm Purchase | 13G | Benitec Biopharma Inc. BNTC | JANUS HENDERSON GROUP PLC JHG | 206,170 9.900% | 206,170 (New Position) | View |
| 2023-08-18 10:50 am Sale | 13G | Benitec Biopharma Inc. BNTC | Oliveira Steven Michael | 98,203 3.890% | -1,985,968 (-95.29%) | View |